Browse > Article
http://dx.doi.org/10.4070/kcj.2012.42.2.129

Catecholaminergic Polymorphic Ventricular Tachycardia in a Patient With Recurrent Exertional Syncope  

Kim, Na-Young (Department of Internal Medicine, Kyungpook National University School of Medicine)
Kang, Jung-Kyu (Department of Internal Medicine, Kyungpook National University School of Medicine)
Park, Sun-Hee (Department of Internal Medicine, Kyungpook National University School of Medicine)
Bae, Myung-Hwan (Department of Internal Medicine, Kyungpook National University School of Medicine)
Lee, Jang-Hoon (Department of Internal Medicine, Kyungpook National University School of Medicine)
Yang, Dong-Heon (Department of Internal Medicine, Kyungpook National University School of Medicine)
Park, Hun-Sik (Department of Internal Medicine, Kyungpook National University School of Medicine)
Chae, Shung-Chull (Department of Internal Medicine, Kyungpook National University School of Medicine)
Jun, Jae-Eun (Department of Internal Medicine, Kyungpook National University School of Medicine)
Cho, Yong-Keun (Department of Internal Medicine, Kyungpook National University School of Medicine)
Publication Information
Korean Circulation Journal / v.42, no.2, 2012 , pp. 129-132 More about this Journal
Abstract
A 16-year-old male with a prior history of recurrent syncope was referred to our hospital after being resuscitated from cardiac arrest developed while playing volleyball. His electrocardiogram (ECG) demonstrated ventricular fibrillation at a local emergency department. After referral, an ECG showed bidirectional ventricular tachycardia (VT) and nonsustained Torsade de Pointes. Two days later, his heart rate became regular, and no additional episodes of VT were observed. His ECG showed sinus rhythm with a corrected QT interval of 423 msec, and two-dimensional echocardiography was unremarkable. We made the diagnosis of a catecholaminergic polymorphic VT. However, only premature ventricular complex bigeminy was induced on exercise ECG and epinephrine infusion tests, and the patient showed no episodes of syncope. His father and mother had different missense mutations in the cardiac ryanodine receptor on genetic testing. The proband had both mutations in different alleles and was symptomatic. It was recommended that the patient avoid competitive physical activities, and a ${\beta}$-blocker was prescribed.
Keywords
Catecholamines; Tachycardia, ventricular; Genetics; Syncope; Exercise;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Horner JM, Ackerman MJ. Ventricular ectopy during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm 2008;5:1690-4.   DOI   ScienceOn
2 Krahn AD, Healey JS, Chauhan V, et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Circulation 2009;120: 278-85.   DOI   ScienceOn
3 George CH, Higgs GV, Lai FA. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 2003;93:531-40.   DOI   ScienceOn
4 Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74.   DOI   ScienceOn
5 Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001;103:2822-7.   DOI   ScienceOn
6 Nam GB, Burashnikov A, Antzelevitch C. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation 2005;111:2727-33.   DOI   ScienceOn
7 di Barletta MR, Viatchenko-Karpinski S, Nori A, et al. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 2006;114:1012-9.   DOI   ScienceOn
8 Maron BJ, Chaitmann BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004;109; 2807-16.   DOI   ScienceOn
9 Hayashi M, Denjoy I, Extramiana F, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009;119:2426-34.   DOI   ScienceOn
10 Postma AV, Denjoy I, Kamblock J, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005;42:863-70.   DOI
11 Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 1995;91:1512-9.   DOI   ScienceOn
12 Watanabe H, Chopra N, Laver D, et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009;15:380-3.   DOI   ScienceOn
13 Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008;358:2024-9.   DOI   ScienceOn